What Doccla does

Doccla is a UK-headquartered virtual care company that operates technology-enabled virtual wards and remote patient monitoring services for the NHS and other European health systems. Founded in 2019 by Martin Ratz and Dag Larsson, the company is headquartered in Hammersmith, London, and operates across 11 European countries including the UK, Ireland, France, and the DACH region. Its core customers are NHS Integrated Care Systems, NHS acute and community Trusts, primary care networks, HSE Ireland, and international health systems such as Charité Berlin, with named deployments at 40+ NHS trusts covering over 60% of NHS regions.

The Doccla platform combines a Patient App, Clinician Dashboard, and Patient Referral Service with managed service modules covering Proactive Care, CQC-registered Clinical Monitoring, Patient Support (compliance), Compatible Devices, and end-to-end Device Logistics. The technology stack integrates Bluetooth-enabled clinical-grade wearables with AI-enabled remote patient monitoring — machine learning models combine NHS records with wearable vital sign data to flag at-risk patients on metrics such as oxygen saturation, blood pressure, and ECG readings, with bidirectional EHR integration including Oracle Cerner. Doccla is CQC-registered, ISO 27001 and ISO 13485 certified, compliant with NHS DSPT, NHS DTAC, GDPR, UKCA, and CE, and supports a multilingual patient app (English, Bengali, French, German, Gujarati, Italian, Polish, Welsh). Reported outcomes include a 34% reduction in non-elective admissions (BNSSG ICB 2024), £3,900 annual cost savings per patient (LLR ICB 2025), and a £1.96 cost-benefit ratio per £1 invested at planned capacity.

The business model is predominantly subscription-based, with custom annual contracts negotiated directly with NHS bodies and other healthcare providers under value-based pricing tied to outcomes. A secondary revenue stream supports life sciences and pharmaceutical clients with remote monitoring for decentralized clinical trials. Doccla has raised approximately £57M+ in cumulative venture funding across a £2.4M seed (Giant Ventures, Speedinvest, 2021), £15M Series A (General Catalyst, 2022), €5M strategic investment (Bertelsmann Investments, 2023), and £35M Series B (Lakestar, 2024), and acquired OpenTeleHealth (OTH) in August 2023 to accelerate its European footprint.

Name

Doccla

Legal name

Doccla UK Limited

Website

https://doccla.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

101–250 employees

Short description

Doccla provides technology-enabled virtual wards and remote patient monitoring services to NHS Integrated Care Systems, NHS Trusts, and European health systems across 11 countries, combining AI-enabled vital sign monitoring, CQC-registered clinical services, device logistics, and bidirectional EHR integration.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring

NAICS

Home Health Care Services (621610), Offices of Physicians (62111)

SIC

Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)

akta.pro secondary industries

AI/Analytics for RPM (Risk Stratification, Alerts, Predictive) (HLACAFAM), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD), Care Pathway Automation & Patient Engagement for RPM (Coaching, Messaging, Scheduling) (HLACAPAM)

Keywords

• Virtual ward services
• Remote patient monitoring
• Proactive care solutions
• Clinical monitoring services
• Hospital at home

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. NHS Contracts - Virtual Ward Services: Doccla generates revenue through contracts with NHS trusts, integrated care systems, and healthcare providers for virtual ward and remote patient monitoring services. The company provides end-to-end managed services including technology, clinical monitoring, device logistics, and patient support. Pricing follows value-based care models with demonstrated ROI through reduced emergency admissions and hospital bed days.
2. Life Sciences & Pharmaceutical Research: Doccla supports clinical trials and pharmaceutical research through remote monitoring capabilities, enabling decentralized trials and real-world evidence collection from patients in their homes.
3. Clinical Monitoring Services: CQC-registered clinical team provides ongoing monitoring services including alert review, virtual consultations, MDT participation, and prescribing services for NHS partners.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Doccla provides tech-enabled virtual ward and remote patient monitoring services, combining a proprietary AI/ML-enabled monitoring platform (Patient App, Clinician Dashboard, EHR integration, Bluetooth wearables) with a CQC-registered in-house clinical team and end-to-end device logistics. The platform allows patients to receive hospital-level care at home while clinicians monitor vitals such as oxygen saturation, blood pressure, and ECG in real time, serving NHS trusts, ICBs, primary care networks, and international health systems.

Product overview

Doccla operates as a virtual care platform combining a modular system of Patient App, Clinician Dashboard, and Patient Referral Service with supporting service modules including Proactive Care, Clinical Monitoring, Patient Support, Compatible Devices, and Device Logistics. The platform enables Virtual Wards that allow patients to receive hospital-level care at home through connected medical devices and real-time clinical monitoring. The AI-enabled remote patient monitoring feature uses machine learning to predict patient deterioration, while the recently launched Comfort Tracker supports end-of-life care at home. Doccla's core value proposition is delivering proactive, preventative care that reduces hospital admissions by identifying at-risk patients early and intervening before crises occur.

Differentiator

Problem solved

Functional benefit

Products and services

• Doccla Platform Core technology platform comprising the Patient App, Clinician Dashboard and Patient Referral Service that enables healthcare providers to deliver remote patient monitoring and virtual ward programmes. For NHS trusts, ICBs, primary care networks, life sciences organisations and international health systems.
• Virtual Wards Technology-enabled care delivery service that allows patients to receive hospital-level care at home, monitored remotely by clinical teams through connected medical devices and the Doccla platform. For NHS trusts, ICBs, primary care networks and international health systems.
• Proactive Care Long-term, lower-intensity support service focused on prevention, self-management and patient engagement for chronic conditions, using population health data for risk stratification to deliver targeted interventions before deterioration.
• Clinical Monitoring CQC-registered clinical monitoring service in which Doccla's nurses, GPs, paramedics and consultants provide remote patient monitoring, alert review, virtual consultations, MDT participation, prescribing and escalation services for NHS partners.
• Patient Support Dedicated patient support team that remotely onboards patients, guides them through device setup, monitors engagement and follows up on missed readings, providing a 365-day support line.
• Compatible Devices Range of clinical-grade wearable and medical devices compatible with the Doccla platform for monitoring patient vital signs, including blood pressure monitors, pulse oximeters, thermometers and ECG devices.
• Device Logistics End-to-end logistics service that delivers, tracks and manages medical devices direct to patients or hospitals, handling stock levels, returns and fleet asset management so clinicians can focus on care.
• Comfort Tracker Home-based end-of-life monitoring tool co-developed with NHS clinicians to support patients in palliative care settings, enabling dignified care at home.

Quantifiable outcome

• 34% reduction in non-elective admissions (BNSSG ICB - 2024)
• +12 more outcomes

Named customers16 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature8 records

Partnerships

Four partnerships are on record, tiered flagship, strategic, minor and core.

• Health Service Executive (HSE) IrelandflagshipStrategic or Co-development Partner · 19 December 2025HSE Ireland expanded Doccla's virtual ward service to all seven health regions in Ireland, making virtual ward care available across the entire country to reduce unnecessary hospital stays.
• Charité BerlinstrategicStrategic or Co-development Partner · 19 September 2025Charité Berlin partnered with Doccla for a research study on telemonitoring in Germany. This represents Doccla's first customer partnership in Germany as part of its European expansion.
• Flying HealthminorStrategic or Co-development Partner · 3 September 2024Doccla partnered with Flying Health to host discussion roundtables on NHS digital transformation and virtual care adoption in Germany.
• OTH (Orchestrated Health)coreTechnology or Integration · 18 August 2023Doccla acquired SaaS company OTH to expand its technology capabilities and enable virtual wards at scale. The acquisition opened doors to ten new markets including Sweden.

Scale indicators14 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Huma: Huma (formerly Medopad) is a London-based digital health platform providing remote patient monitoring and virtual ward solutions, with deep NHS partnerships. It is the closest direct competitor to Doccla in the UK NHS virtual ward market, offering similar RPM, patient apps, and clinician dashboards.
• Luscii: Luscii is a Netherlands-based remote patient monitoring and virtual care platform serving health systems across Europe, including NHS-adjacent deployments. Comparable to Doccla in offering a clinician dashboard, patient app, and library of condition-specific remote monitoring pathways at scale across multiple countries.
• Clinitouch (Spirit Health Group): Clinitouch, developed by Spirit Health Group, is a UK remote patient monitoring platform used by NHS trusts for virtual ward and chronic condition management. It directly competes with Doccla for NHS virtual ward contracts, particularly in respiratory and long-term condition pathways.
• Biofourmis: Biofourmis is a US-based AI-driven remote patient monitoring and virtual care platform focused on hospital-at-home and post-acute care. It competes with Doccla on AI-enabled RPM, multi-condition care pathways, and pharma decentralised trial enablement.
• Current Health (Best Buy Health): Current Health (acquired by Best Buy Health in 2022) provides an FDA-cleared remote patient monitoring platform for hospital-at-home and virtual ward programmes in the US and UK. It is a direct competitor to Doccla's tech-agnostic virtual ward offering, particularly for hospital systems launching virtual care programmes.
• Vivify Health (Optum): Vivify Health, now part of Optum (UnitedHealth Group), provides a remote patient monitoring platform used by health systems and plans for chronic condition management and post-acute care. It is comparable to Doccla in combining RPM devices, patient engagement tools, and clinician workflows.

Broad incumbents

• Medtronic Care Management Services: Medtronic operates remote cardiac monitoring and broader care management services, particularly for heart failure and chronic cardiac conditions. It overlaps with Doccla's cardiometabolic RPM capabilities, including CHF and hypertension pathways, as part of a broader medtech portfolio.
• Philips Remote Patient Monitoring: Philips is a large incumbent medical technology company with a remote patient monitoring portfolio covering hospital telehealth, chronic care, and population health. While it serves a broader portfolio of customers than Doccla, its RPM and hospital-at-home offerings overlap directly with Doccla's virtual ward positioning.
• GE HealthCare: GE HealthCare offers command-center style virtual care and remote monitoring solutions for hospitals and health systems globally. As a large incumbent with established hospital relationships, it competes with Doccla for virtual ward and centralised monitoring deployments, particularly in larger integrated delivery networks.

Emerging players

• Hinge Health: Hinge Health is a digital musculoskeletal and chronic pain platform combining remote monitoring, exercise therapy, and clinician coaching. While focused on a single therapeutic area (MSK), it overlaps with Doccla's Proactive Care chronic-condition model and digital therapeutic coaching approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PLM5TQHEAjKFc6TQLgpNhonKY9jHAcgWEf
• LinkedInlinkedin.com/company/doccla
• Facebookfacebook.com/docclahealth
• Xx.com/DocclaUK

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doccla